Effect of drug utilization reviews on the quality of in-hospital prescribing: A quasi-experimental study

BMC Health Services Research

Volumn 6, Issue , 2006, Pages

  Grégoire, Jean Pierre ^a,b   Moisan, Jocelyne ^a,b   Potvin, Louise ^c   Chabot, Isabelle ^a,b   Verreault, René ^a,b   Milot, Alain ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; CISAPRIDE; CLARITHROMYCIN; DOMPERIDONE; ERYTHROMYCIN; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; ITRACONAZOLE; KETOCONAZOLE; LANSOPRAZOLE; METOCLOPRAMIDE; NEFAZODONE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; WARFARIN; GASTROINTESTINAL AGENT;

ARTICLE; COMPARATIVE STUDY; DRUG USE; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY DISORDER; HISTORY OF MEDICINE; HOSPITAL; HUMAN; MEDICAL RECORD; PRESCRIPTION; PSEUDOOBSTRUCTION; QUALITY CONTROL; QUASI EXPERIMENTAL STUDY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH PARESIS; STUDENT T TEST; UNIVERSITY HOSPITAL; CANADA; CLINICAL PRACTICE; CONTROL GROUP; HOSPITAL PHARMACY; MEDICAL AUDIT; PROCEDURES; STANDARDS; TEACHING HOSPITAL; UTILIZATION REVIEW;

CISAPRIDE; CONCURRENT REVIEW; CONTROL GROUPS; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; GASTROINTESTINAL AGENTS; HOSPITALS, TEACHING; HUMANS; MEDICAL AUDIT; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; QUEBEC; RETROSPECTIVE STUDIES;

EID: 33645673417     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-6-33     Document Type: Article

References (25)

1. Stolar MH: Drug use review: operational definitions. American Journal of Hospital Pharmacy 1978, 35:76-78.
2. Lipton HL, Bird JA: Drug utilization review in ambulatory settings: state of the science and directions for outcomes research. Medical Care 1993, 31:1069-1082.
3. The ASHP Council on Professional Affairs: ASHP guidelines on the pharmacist's role in drug use evaluation. American Journal of Hospital Pharmacy 1988, 45:385-386.
4. Soumerai SB, Avorn J: Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Milbank Mem Fund Q Health Soc 1984, 62:447-474.
5. Soumerai SB, McLaughlin TJ, Avorn J: Improving drug prescribing in primary care: a critical analysis of the experimental literature. The Milbank Quarterly 1989, 67:268-317.
6. Hennessy S, Strom BL, Lipton HL, Soumerai SB: Drug utilization review. In Pharmacoepidemiology Third edition. Edited by: Strom BL. New York, John Wiley & Sons, Ltd.; 2000:505-523.
7. Cook TD: Quasi-experiments: Interrupted time-series designs. In Quasi-exprimentation Design and analysis issues for field settings Edited by: Cook TD and Campbell DT. Boston, Houghton Mifflir Co; 1979:207-232.
8. Breton MC, Bourbeau K, Cusson J, Gregoire JP, Guevremont C, Labranche S, Milot A, Robert S, St-Laurent M: The Drug utilization review Network of Quebec. Healthcare Management FORUM 1996, 9:44-47.
9. Box GEP, Jenkins GM: Timeseries analysis: Forecasting and control. San Francisco, Holden-Day; 1970.
10. Box GEP, Tiao GC: Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc 1975, 70:70-79.
11. McCain LJ, McCleary R: The statistical analysis of the simple interrupted time-series quasi-experiment. In Quasi-experimentation Design and analysis issues for field settings Edited by: Cook TD and Campbell DT. Boston, Houghton Mifflir Co; 1979:233-293.
12. Tukey JW: Exploratory Data Analysis. Reading, MA., Addison-Wesley; 1977.
13. SAS Institute Inc.: SAS OnlineDoc, Version 8. .
14. Soumerai SB, Majumdar S, Lipton HL: Evaluating and improving physician prescribing. In Pharmacoepidemiology Third edition. Edited by: Strom BL. New York, John Wiley & Sons, Ltd.; 2000:483-503.
15. Soumerai SB, McLaughlin TJ, Gurwitz JH, Guadagnoli E, Hauptman PJ, Borbas C, Morris N, McLaughlin B, Gao X, Willison DJ, Asinger R, Gobel F: Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. Journal of the American Medical Association 1998, 279:1358-1363.
16. Ross-Degnan D, Soumerai SB, Fortess EE, Gurwitz JH: Examining product risk in context. Market withdrawal of zomepirac as a case study. Journal of the American Medical Association 1993, 270:1937-1942.
17. Smalley W, Shatin D, Wysowski DK, Gurwitz J, Andrade SE, Goodman M, Chan KA, Platt R, Schech SD, Ray WA: Contraindicated use of cisapride: impact of food and drug administration regulatory action. Journal of the American Medical Association 2000, 284:3036-3039.
18. Majumdar SR, Soumerai SB: Why most interventions to improve physician prescribing do not seem to work. Canadian Medical Association Journal 2003, 169:30-31.
19. Comité scientifique: Rapport d'utilisation des procinétiques dans les désordres de la motilité gastro-intestinale. Montréal, Réseau de revue d'utilisation des médicaments; 1999:1-5.
20. Monane M, Matthias DM, Nagle BA, Kelly MA: Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. Journal of the American Medical Association 1998, 280:1249-1252.
21. Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW: Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000, 160:2741-2747.
22. Okano GJ, Rascati KL: Effects of Medicaid drug utilization review intervention letters. Clin Ther 1995, 17:525-33; discussion 516.
23. Collins TM, Mott DA, Bigelow WE, Zimmerman DR: A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach. Health Serv Res 1997, 32:471-489.
24. Smith DH, Christensen DB, Stergachis A, Holmes G: A randomized controlled trial of a drug use review intervention for sedative hypnotic medications. Medical Care 1998, 36:1013-1021.
25. Soumerai SB, Avorn J: Principles of educational outreach (academic detailing) to improve clinical decision making. Journal of the American Medical Association 1990, 263:549-556.